Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients.

J M Ruiz-MorenoFernando de Andrés-Nogales Itziar Oyagüez

Published in: BMC ophthalmology (2020)

To extend the anti-VEGF loading dose from 3 to 6 injections necessitates investing €5882.77 (8 injections), €10,091.03 (14 injections) and €10,198.59 (30 injections) per additional responder patient (3-month nonresponders and 6-month responders) to aflibercept, ranibizumab and bevacizumab, respectively. For the total of patients treated, on average €7927.02 (14 injections) per additional responder patient would be needed.

Keyphrases

platelet rich plasma
ultrasound guided
end stage renal disease
case report
ejection fraction
endothelial cells
chronic kidney disease
newly diagnosed
peritoneal dialysis
patient reported outcomes
optical coherence tomography